On July 17, 2024, the U.S. Patent and Trademark Office (the Office) released new guidance on subject matter eligibility, entitled “The 2024 Patent Subject Matter Eligibility Guidance Update Including ...
Enter the Royal Society in London – the UK’s national academy of science – and you will see a three-word phrase: “nullius in verba“. This motto, held for over 350 years, translates to “take nobody’s ...
The US Food and Drug Administration (FDA) is offering a detailed look at how real-world evidence sources – from registries to claims data – can be used to support marketing applications for medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results